Sankaijo BOTANICAL LAXATIVE — Class III drug recall D-0303-2020
Terminated recall by Sato Pharmaceutical Inc., reported 2019-11-13, distributed nationwide. Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
| Recall number | D-0303-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sato Pharmaceutical Inc., Torrance, CA, United States |
| Recall initiated | 2019-10-01 |
| Classified | 2019-11-07 |
| Reported by FDA | 2019-11-13 |
| Terminated | 2020-08-18 |
| Distributed | Nationwide (US) |
| Quantity | 17,284 bottles |
| Reason classes | potency |
| NDC | 49873-0404, 49873-0404-01 |
Product
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
Reason for recall
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0303-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.